Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivacaftor in Cystic Fibrosis with G551D Mutation
NCT01937325Phase 4Unknown
- Sponsor
- Alfred Health
- Start
- Feb 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ivacaftor in cystic fibrosis (CF), sponsored by Alfred Health. Status: unknown.
02
Drugs
ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01937325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937325.